FDA Drug Recalls

Recalls / Class II

Class IID-0463-2019

Product

Sermorelin, 15mg, injection, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684

Affected lot / code info
Lots: 07102018@4 BUD: 1/6/2019; 09142018@6 BUD: 3/13/2019; 10052018@4 BUD: 4/3/2019; 11062018@1 BUD: 5/5/2019

Why it was recalled

Lack of sterility assurance.

Recalling firm

Firm
Promise Pharmacy, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
31818 Us Highway 19 N, N/A, Palm Harbor, Florida 34684-3713

Distribution

Quantity
266 vials
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2018-12-17
FDA classified
2019-02-08
Posted by FDA
2019-02-20
Terminated
2021-03-30
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0463-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls